<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108591-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Le r&#xF4;le de l&#x2019;IL6 dans le cancer du foie li&#xE9; &#xE0; l&#x2019;h&#xE9;patopathie m&#xE9;tabolique</narrative>
   <narrative xml:lang="EN">The role of IL6 in liver cancer linked to metabolic liver disease</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Le cancer du foie est souvent mortel. Il n&#x2019;existe que tr&#xE8;s peu d&#x2019;options de traitement, et il s&#x2019;agit de l&#x2019;un des cancers dont l&#x2019;incidence augmente dans le monde entier. L&#x2019;ob&#xE9;sit&#xE9; ou les maladies m&#xE9;taboliques (comme le diab&#xE8;te et la st&#xE9;atose h&#xE9;patique) constituent des facteurs de risque du cancer du foie qui sont mal compris. Puisque ces conditions atteignent des proportions &#xE9;pid&#xE9;miques dans bon nombre de pays, on s&#x2019;attend &#xE0; ce que la pr&#xE9;valence du cancer du foie continue d&#x2019;augmenter. 

Afin de trouver des moyens novateurs de traiter le cancer du foie, le pr&#xE9;sent projet vise &#xE0; identifier les prot&#xE9;ines et les voies cellulaires qui influent sur le d&#xE9;veloppement et la croissance des tumeurs h&#xE9;patiques, plus particuli&#xE8;rement celles li&#xE9;es &#xE0; l&#x2019;ob&#xE9;sit&#xE9;. L&#x2019;&#xE9;quipe tentera de d&#xE9;terminer si une nouvelle voie de signalisation de l&#x2019;interleukine 6 (IL6) contr&#xF4;le le d&#xE9;veloppement de tumeurs h&#xE9;patiques chez des souris rendues ob&#xE8;ses avec une alimentation riche en sucre et en gras, et chez des patients ob&#xE8;ses atteints d&#x2019;un cancer du foie. L&#x2019;IL6 est une hormone qui circule dans le sang et pourrait donc &#xEA;tre &#xE0; la fois un nouveau biomarqueur du cancer du foie et une nouvelle cible th&#xE9;rapeutique pour traiter la maladie. 

Le projet est dirig&#xE9; au Canada par l&#x2019;Institut de recherches cliniques de Montr&#xE9;al, en collaboration avec le Hadassah Medical Centre (Isra&#xEB;l) et la Dokuz Eyl&#xFC;l University (Turquie). Il a &#xE9;t&#xE9; retenu aux fins de financement au cours du troisi&#xE8;me concours de recherche du Programme conjoint canado-isra&#xE9;lien de recherche en sant&#xE9;, un partenariat entre le CRDI, les Instituts de recherche en sant&#xE9; du Canada, l&#x2019;Israel Science Foundation et l&#x2019;Azrieli Foundation.</narrative>
   <narrative xml:lang="EN">Liver cancer is highly fatal, it has very few treatment options, and it is one of the few cancers whose incidence is rising worldwide. One poorly understood risk factor for liver cancer is obesity/metabolic disease (such as diabetes and fatty liver disease). Since these conditions are reaching epidemic proportions in many countries, the prevalence of liver cancer is expected to continue to rise. 

In order to find innovative ways to treat liver cancer, this project aims to identify proteins and cell pathways that influence liver tumour development and growth, specifically in obesity. The team will investigate whether a new signaling pathway for interleukin 6 (IL6) controls liver tumour development in mice that have been made obese by diets high in sugar and fat, and in obese patients with liver cancer. IL6 is a hormone that circulates in the blood, and thus has the potential to be both a new biomarker of liver cancer and a new therapeutic target to treat the disease. 

The project is led in Canada by the Institut de recherches cliniques de Montr&#xE9;al with the collaboration of the Hadassah Medical Centre (Israel), and the Dokuz Eylul University (Turkey). It was selected for funding through the third research competition of the Joint Canada-Israel Health Research Program, a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Azrieli Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="2" type="24">
   <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
  </participating-org>
  <participating-org role="4" type="24">
   <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2017-11-01" type="2"></activity-date>
  <activity-date iso-date="2022-01-11" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-01"></transaction-date>
   <value currency="CAD" value-date="2017-12-01">166667</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-01"></transaction-date>
   <value currency="CAD" value-date="2017-12-01">166667</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-01"></transaction-date>
   <value currency="CAD" value-date="2017-12-01">503333</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-12-01"></transaction-date>
   <value currency="CAD" value-date="2017-12-01">503333</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-04"></transaction-date>
   <value currency="CAD" value-date="2017-12-04">30757</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-04"></transaction-date>
   <value currency="CAD" value-date="2017-12-04">92885</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-05-01"></transaction-date>
   <value currency="CAD" value-date="2018-05-01">30756</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-05-01"></transaction-date>
   <value currency="CAD" value-date="2018-05-01">92885</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-11-02"></transaction-date>
   <value currency="CAD" value-date="2018-11-02">26036</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-11-02"></transaction-date>
   <value currency="CAD" value-date="2018-11-02">78628</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-06-07"></transaction-date>
   <value currency="CAD" value-date="2019-06-07">26035</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-06-07"></transaction-date>
   <value currency="CAD" value-date="2019-06-07">78628</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-11-01"></transaction-date>
   <value currency="CAD" value-date="2019-11-01">26540</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-11-01"></transaction-date>
   <value currency="CAD" value-date="2019-11-01">80152</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-140126</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-423180</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">140126</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">423180</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="CAD" value-date="2020-05-04">18207</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="CAD" value-date="2020-05-04">54985</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">-18207</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">-54985</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">18207</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">54985</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="FR">Institut de recherches cliniques de Montr&#xE9;al</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
